Let there be sleep-on time

The Lancet

Volumn 373, Issue 9662, 2009, Pages 439-441

  Cardinali, Daniel P ^a   Golombek, Diego A ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; HORMONE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN DERIVATIVE; MELATONIN RECEPTOR AGONIST; RAMELTEON; TASIMELTEON; UNCLASSIFIED DRUG;

ARTICLE; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; DRUG APPROVAL; DRUG CHOICE; DRUG DESIGN; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; HUMAN; INSOMNIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SLEEP; SLEEP WAKING CYCLE;

EID: 59249098005     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61813-9     Document Type: Note

References (5)

1. Rajaratnam S.M.W., Polymeropoulos M.H., Fisher D.M., et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 10.1016/S0140-6736(08)61812-7 published online Dec 2
2. Pandi-Perumal S.R., Trakht I., Spence D.W., Srinivasan V., Dagan Y., and Cardinali D.P. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. Nat Clin Pract Neurol 4 (2008) 436-447
3. Lewy A.J. Melatonin and human chronobiology. Cold Spring Harb Symp Quant Biol 72 (2007) 623-636
4. Reynoldson J.N., Elliott Sr. E., and Nelson L.A. Ramelteon: a novel approach in the treatment of insomnia. Ann Pharmacother 42 (2008) 1262-1271
5. Pandi-Perumal S.R., Trakht I., Srinivasan V., et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85 (2008) 335-353